A Phase II Randomized Discontinuation Trial Of Carboxyaminoimidazole (CAI, NSC 609974) [L 651582] In Metastatic Renal Carcinoma
Latest Information Update: 17 Jan 2013
At a glance
- Drugs L 651582 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 17 Sep 2005 New trial record.